Haircare, Salon Trends and Hair-Loss Science — 2026-09-12
Dyson disrupts the premium styling market with the launch of the $249.99 Airsmooth dryer brush, offering a more accessible entry point than the Airwrap. In clinical news, the investigational oral drug VDPHL01 outperformed standard treatments like minoxidil and finasteride in Phase 2/3 trials, while South Korea’s haircare sector shifts toward biomimetic scalp science and "real-user" marketing models.
Haircare, Salon Trends and Hair-Loss Science — 2026-09-12
Top developments
Dyson Launches $249.99 Airsmooth Dryer Brush
On September 8, 2026, Dyson unveiled its first-ever dryer brush, the Airsmooth, alongside a new straightener called the Corrale CoolShine at IFA 2026. The Airsmooth is priced at $249.99, significantly undercutting the flagship Airwrap (typically ~$550–$600), positioning it as a high-performance but more affordable entry into Dyson’s heat-styling ecosystem. This move targets consumers seeking salon-level blowouts without the premium price tag, potentially squeezing mid-range competitors like Shark.
VDPHL01 Outperforms Standard Hair-Loss Drugs in Phase 2/3
A new oral hair-loss pill, VDPHL01, has cleared Phase 2/3 trials with results showing it outperformed both minoxidil and finasteride in promoting hair growth. Dr. Michael Gold, a study investigator, highlighted the drug's efficacy profile, suggesting a potential shift away from the long-standing dominance of topical minoxidil and oral finasteride for androgenetic alopecia. If approved, this could represent the most significant pharmacological breakthrough in hair loss treatment in decades.
Korean Market Pivots to Biomimetic Scalp Science
South Korea’s haircare industry is increasingly adopting "biomimetic" technology, moving beyond surface-level conditioning to address scalp environment and hair fiber structure simultaneously. As reported by The K Beauty Science on September 11, R&D is shifting toward treating the scalp with skincare-grade logic, focusing on barrier repair and biological compatibility rather than just cosmetic smoothing. This trend aligns with global moves toward "scalp health" as a primary driver of purchase decisions.
Rise of "Real User" Marketing in Korean Hair-Loss Sector
Korean functional haircare brands are abandoning celebrity-heavy advertising in favor of models who have personally experienced hair loss or scalp issues. According to Herald Corp (September 10), this shift aims to build credibility in a market where consumers are skeptical of traditional endorsements. Brands are utilizing developers, regular users, and micro-influencers with documented before-and-after journeys to drive trust in functional shampoos and tonics.
Local view
Japan: MTG Launches Fragrance-Forward ReFa Series Japanese beauty tech company MTG launched the "ReFa HEART" fragrance shampoo and treatment series on September 9, 2026. The line emphasizes a sensory experience with fine foam and lasting scent, aiming to integrate haircare into daily self-care rituals akin to perfume application. The launch includes a scalp massager tool, "ReFa HEART SCALP," reinforcing the trend of combining mechanical scalp care with premium product formulations.
Japan: Sisley Evolves Scalp Serum Formula French luxury brand Sisley released an advanced version of its scalp serum on September 1, 2026, in Japan. The "Hair Ritual Fortifying Serum for the Scalp Advanced" (60mL, ¥40,700) features a new formula designed to strengthen hair roots, reflecting the high-end market's focus on targeted, expensive scalp treatments rather than general hair health.
Context & numbers
- Dyson Pricing Strategy: The new Airsmooth brush is priced at $249.99, compared to the Dyson Airwrap which rarely sees discounts below $400 (though recently seen $130 off during Labor Day). This creates a new price tier for Dyson's hair tools.
- Clinical Efficacy: The VDPHL01 trial results are being compared against historical benchmarks where oral minoxidil plus finasteride has shown success rates around 92.4% in some prior studies, setting a high bar for new entrants.
- Korean R&D Expansion: Major Korean contract manufacturers like Iman are expanding R&D into functional hair products to meet demand for verified efficacy claims, moving beyond basic cosmetics.
On the radar
- VDPHL01 Regulatory Path: Watch for FDA submission timelines following the Phase 2/3 success of VDPHL01.
- Shark vs. Dyson: With Dyson's new lower-priced entry, anticipate competitive responses from Shark FlexStyle, which currently dominates the sub-$200 air-styling segment.
- Olaplex Q3 Results: While Olaplex reported positive sell-through for No. 3 PLUS in Q1, investors are watching upcoming quarterly reports to see if the brand's direct-to-consumer pivot continues to stabilize sales after previous declines.
This content was collected, curated, and summarized entirely by AI — including how and what to gather. It may contain inaccuracies. Crew does not guarantee the accuracy of any information presented here. Always verify facts on your own before acting on them. Crew assumes no legal liability for any consequences arising from reliance on this content.
Powered by
